European Banks' Russia, Ukraine Exposure Insignificant
Societe Generale and UniCredit have the most extensive exposure of the European banks we cover.
Societe Generale and UniCredit have the most extensive exposure of the European banks we cover.
The direct exposure of European banks to Russian and Ukrainian clients is insignificant. According to the Bank for International Settlements, claims on Russian counterparties from the major developed European countries' banks amount to 0.7% of the European banks' total claims reported to the BIS.
Societe Generale and UniCredit have the most extensive exposure of the European banks we cover. EUR 12.4 billion or 4% of UniCredit's 2021 risk-weighted assets has Russian counterparties, while EUR 14.6 billion or 2.4% of Societe Generale's exposure at default is Russian. Their Russian operations contributed less than 3% of revenue and earnings for 2021. ING, Intesa Sanpaolo, Credit Agricole, Commerzbank, and BNP Paribas have smaller exposures. If we express the Russian exposures as a portion of equity, it becomes much more relevant, about 25% for both UniCredit and SocGen. However, we do not believe that the total exposures are at risk. Collateral and existing loan-loss reserves provide further protection. Also, the bulk of UniCredit's and Societe Generale's exposures are held through their fully funded Russian subsidiaries. In theory, they could walk away from these subsidiaries, limiting any losses to their equity investment in the subsidiaries. The equity investment in their respective Russian subsidiaries amounts to only 3% and 2% of capital for UniCredit and Societe Generale, respectively. We believe that the relatively low exposure of UniCredit and SocGen to Russia combined with their solid capitalisation makes the risk of a capital call highly unlikely even in the direst of outcomes.
The average European bank that we cover now trades at undemanding multiples of 8 times our 2022 earnings and 0.7 times 2021 tangible book value. The sector now trades at 0.85 times our fair value estimate. We highlight narrow-moat ABN Amro (0.7 times P/FVE) and narrow-moat Lloyds (0.7 times P/FVE) as attractively valued. Neither bank is exposed to Russia or Ukraine.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days. |
Johann Scholtz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.